ID Name Structure References (top 5) Molecular Target(s)
1ID:1636
DEOXYCHOLIC ACID


NSC#:8797
NSC#:224323
Aldrich#:107301
Aldrich#:30960
Aldrich#:D2510
Aldrich#:R203513
Aldrich#:R218952
Aldrich#:S961248
Aldrich#:S964735
Aldrich#:S964743
Aldrich#:S965294

Freqency:
in 1 ingredients:

  • 52
  • in 8 recipes:

  • 2
  • 12
  • 100
  • 125
  • 205
  • 217
  • 271
  • 380

  • Properties
    C24H40O4    392.58





    1:  Talwalkar JA.
    Markov models in primary biliary cirrhosis.
    Gastroenterology.    impact factor:   12.182
    2002;  123(5): 1750-1

    2:  Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M.
    Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
    Gastroenterology.    impact factor:   12.182
    2002;  123(4): 1238-51

    3:  Prince M, Chetwynd A, Newman W, Metcalf JV, James OF.
    Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.
    Gastroenterology.    impact factor:   12.182
    2002;  123(4): 1044-51

    4:  Blendis L, Lurie Y.
    Primary sclerosing cholangitis: a premalignant condition.
    Gastroenterology.    impact factor:   12.182
    2002;  123(2): 647-8

    5:  Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ, Kullak-Ublick GA.
    Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Gastroenterology.    impact factor:   12.182
    2002;  122(7): 1954-66

     
    Time used: 156 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005